Report Company Directory

Biosynex SA

• Biosynex: 1 director by SmartInsider
• BIOSYNEX annonce le très vif succès de son augmentation de capital par voie de placement auprès d'investisseurs qualifiés pour un montant de 15 millions d’euros by BusinessWire
• BIOSYNEX annonce le lancement d’une augmentation de capital par voie de placement auprès d'investisseurs qualifiés pour un montant minimum de 8 millions d’euros by BusinessWire
• BIOSYNEX : Chiffre d’affaires 2020 à 154 M€ (x4,4) by BusinessWire
• BIOSYNEX : Calendrier financier 2021 by BusinessWire
• BIOSYNEX ANTICIPE LA POURSUITE DE LA BONNE ORIENTATION DE SON ACTIVITÉ COMMERCIALE AU 1ER SEMESTRE 2021 by BusinessWire
• BIOSYNEX : DÉCLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 30 NOVEMBRE 2020 by BusinessWire
• BIOSYNEX RÉVISE À LA HAUSSE SON OBJECTIF DE CHIFFRE D‘AFFAIRES 2020 AVEC UNE FOURCHETTE COMPRISE ENTRE 150 M€ ET 170 M€ by BusinessWire
• BIOSYNEX : FORTE CROISSANCE DES RÉSULTATS SEMESTRIELS 2020 by BusinessWire
• BIOSYNEX : CROISSANCE ELEVEE DES RÉSULTATS SEMESTRIELS 2021 by BusinessWire

BIOSYNTECH INC

Biotage AB

• Biotage - Saved by the bell by Danske Bank Equity Research
• Biotage - No Rating: Suspension of recommendation and target price by Nordea
• Sartorius reports a decline in LPS sales in Q1 as customers continue to postpone capital equipment investments by Nordea
• Swedish small cap weekly: Week 15 – New addition to the portfolio by Nordea
• Biotage - Buy/SEK 135 (158): Growth recovery in Small Molecules by Nordea
• Swedish small cap weekly: Week 14 – Onwards and upwards by Nordea
• Swedish small cap weekly: Week 13 – Long-term cases intact by Nordea
• Biotage - Astrea business not valued in the share price by Danske Bank Equity Research
• Swedish small cap weekly: Week 12 – Gone global: China and Germany by Nordea
• Biotage - Buy : Wuxi Chemistry beats consensus; growth acceleration in 2025 by Nordea

BIOTAGE AB

• Swedish small cap weekly: Week 15 – New addition to the portfolio by Nordea
• Biotage - Buy/SEK 135 (158): Growth recovery in Small Molecules by Nordea
• Swedish small cap weekly: Week 13 – Long-term cases intact by Nordea
• Swedish small cap weekly: Week 12 – Gone global: China and Germany by Nordea
• Biotage - Buy : Wuxi Chemistry beats consensus; growth acceleration in 2025 by Nordea
• Swedish small cap weekly: Week 10 – New companies on board by Nordea
• Swedish small cap weekly: Week 9 – A triple jackpot by Nordea
• Thermo Fisher guide for solid market growth in 2025 by Nordea
• Danaher Q4 and 2025 guidance by Nordea
• Astrea supplies resins to Thermo Fisher's CaptureSelect products by Nordea

BIOTALYS NV

• Morning Notes : GIMB BB, UCB BB, MAAT FP, BTLS BB by KBC Securities
• Biotalys FIRST LOOK: Good financial management; but focus could be on operational hiccups by KBC Securities
• Morning Notes : AGFB BB, DIE BB, DECB BB, KIN BB, UCB BB, BTLS BB by KBC Securities
• Biotalys Positive first field trial results with 2nd biocontrol BioFun-6 by KBC Securities
• Morning Notes : AD NA, GIMB BB, KIN BB, MDXH BB, SMAR BB, BTLS BB, AUTL US by KBC Securities
• Biotalys FIRST LOOK: The regulatory process marches on by KBC Securities
• Morning Notes : ACKB BB, AGFB BB, UCB BB, BTLS BB, ARG FP by KBC Securities
• Biotalys FIRST LOOK: Fresh cash through € 15m private placement by KBC Securities
• Biotalys FIRST LOOK: BioFun-8 strengthens the pipeline by KBC Securities
• Morning Notes : DSFIR NA, ONTEX BB, SEQUA BB, UCB BB, BTLS BB by KBC Securities